Christoph Correll, MD, discusses how once-monthly subcutaneous olanzapine fills an LAI gap and why continuous coverage matters in schizophrenia.
Christoph Correll, MD
Advertisement
Christoph Correll, MD, is a clinical professor of psychiatry at the Zucker School of Medicine at Hofstra/Northwell.
Articles by Christoph Correll, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Tozorakimab Improves Daily Respiratory Symptoms in COPD: OBERON, TITANIA
2
Asundexian Safely Reduces Ischemic Stroke Risk Regardless of Infarct Patterns on MRI
3
AAD's New HS Guidelines Flag 'Step Therapy' as Top Barrier to Care
4
Frespaciguat Misses 6MWD End Point in PH-COPD: Gabor Kovacs, MD, PhD
5